machine learning for precision medicine, made easy
Reveal the optimal patient profiles for drug therapies, identify biomarkers linked to response, and enable the design of smarter clinical trials, all without the need for bioinformatics expertise.
Big Data and Precision Medicine
For precision medicine, “big data” can be used to identify the genetic and clinical factors responsible for patient variation in clinical outcomes, drug response, or biomarker levels. Conventional analysis of these large datasets can, however, be very time-consuming, highly complex and may require high level bioinformatics expertise, leaving you unable to quickly move your precision medicine projects forward.
Pharmacology-AI makes finding actionable insights from your data quicker and easier. Powered by an explainable machine learning platform, developed in collaboration with IBM and STFC, this automated system rapidly identifies the features driving variation in patient outcomes — streamlining the development of effective patient stratification strategies.
Key Benefits of Pharmacology-AI
View and download AI analysis outputs in an easily interpretable and interactive format via a secure web portal built in compliance with industry standards.
Quickly and easily reveal the genomic or clinical features driving drug response data, biomarker level, or other clinical data outcomes e.g. survival.
Access a unique, explainable precision medicine AI platform developed in collaboration with IBM and STFC.
View quality control results that provide confidence in AI algorithm predictions.
Combine your analysis with preclinical human tissue research to enhance your translational data sets and increase your chances of clinical success.
Pharmacology-AI can identify responsive patient populations
Despite advances in ‘omics’, clinical drug attrition remains high. When used as a stand-alone platform or when combined with our h uman living tissue data, Pharmacology-AI can help identify the optimum patient population for your drug therapy. This allows you to:
- Identify patient profiles most likely to benefit from future trials.
- Enable smarter clinical trial design.
- Improve the chances of clinical trial success
Pharmacology-AI can improve patient outcomes
The Pharmacology-AI Workflow
Who is Pharmacology-AI for?
Scientists and clinicians with clinical or genomic data
If you are looking to obtain useful insights from your existing data, Pharmacology-AI can identify the key features driving biomarker levels, drug response, or clinical outcome. View AI analysis outputs in an easily interpretable and interactive format via a secure portal built in compliance with industry standards.
Inflammatory Bowel Disease (IBD) researchers
Using human living tissue IBD assays, our IBDiscovery service offers a study with your chosen drug to generate data on your target patient population. Our scientists then analyze these data via machine learning to identify the key ‘omic’ or clinical features driving differences in drug or biomarker response.
Whilst Inflammatory bowel disease is our initial area of research focus, the same concept can be applied across a number of organ systems and therapeutic areas. If you would like to utilize this technology in a different area then please contact us to discuss.